HOME >> MEDICINE >> NEWS
AmericasDoctor.com & Affiliated Research Centers announce merger that revolutionizes clinical trial recruitment, expedites pharmaceutical research

Galen Associates, Tullis-Dickerson, Delphi Lead Investment Round; New Company is First 'Clicks & Mortar' Solution to Pharmaceutical Industry Needs

GURNEE, IL / OWINGS MILLS, MD (January 10, 2000) AmericasDoctor.com Inc. and Affiliated Research Centers Inc. announced today that the companies have merged, establishing the first Internet healthcare company to significantly impact the pharmaceutical industry's development of new medicines and therapies.

The new organization will offer business-to-business solutions to unmet research and development needs of the pharmaceutical and contract research organization (CRO) industries, as well as solutions to assist research communications, improve new drug introduction and market positioning. The merger creates the first dedicated Internet solution to volunteer recruitment for clinical trials, the pharmaceutical industry's No. 1 obstacle in getting its products to the marketplace.

The AmericasDoctor.com/Affiliated Research Centers merger is an industry landmark, representing the first time a consumer-oriented Internet entity and a clinical trials management organization have combined resources on a large scale to meet a common objective. Pharmaceutical industry estimates show that a delay in bringing a product to market results in the loss of more than $1 million in revenues each day.

The new "clicks and mortar" organization also represents an early entry into the next generation of Internet healthcare companies, whose business strategy from inception integrates a traditional healthcare entity with the strengths of the Internet. The result offers a revolution in e-research and the role of the Internet to position, promote and develop new pharmaceuticals.

Also announced today, Galen Associates Inc., a leading late-stage healthcare venture group based in New York, has led the new company's initial $16 million investment round. Other venture
'"/>


9-Jan-2000


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
(Date:8/28/2014)... The need for larger space has become more pressing ... new location - 4700 Bryant Irvin Court, Fort Worth, TX ... than TLC had in the past, as well as new ... new location because it represents a good fit for our ... size compared to the current one, the building itself is ...
(Date:8/28/2014)... The next episode of “Extreme Weight Loss” ... He’s a drama coach who longs to audition for ... achieving that dream impossible. , Featuring a unique, non-competitive ... Tuesday, September 2 (9:00-11:00 p.m., ET/PT) on the ABC ... smile on the outside to hide the self-doubt and ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 A St. ... Danis & Lowe reports that the C.R. Bard ... thousands of consolidated transvaginal mesh lawsuits, recently filed a ... #136 pertains to the pretrial discovery process, and more ... sensitive evidence. , Carey Danis & Lowe is a ...
(Date:8/27/2014)... Texas (PRWEB) August 28, 2014 Spine ... prominent online source of information on spinal health. Now, ... back pain, or people suffering from back pain symptoms. ... sciatica surgery, cervical/neck surgery, and lumbar spine surgery. , ... muscle ache, shooting or stabbing pain, pain radiating down ...
(Date:8/27/2014)... DiaSorin has announced that their new ... will feature guest speaker Dr. Gregory A. Plotnikoff, a ... and Healing Integrative Medicine. Dr. Plotnikoff serves as an ... Health and Healing and as Senior Consultant, Center for ... also serves as a co-editor of the new journal ...
Breaking Medicine News(10 mins):Health News:“Extreme Weight Loss”: Rod’s Journey Begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:Spine Guide Offering New Overview of Surgical Options For Back Pain 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 2Health News:DiaSorin Announces New Webinar in Their Annual Vitamin D Series 3
(Date:8/27/2014)... North American lighting leader OSRAM SYLVANIA has been ... OSRAM ITOS ® PHASER ® 3000, the industry,s ... and surgical head lamps that delivers the same brightness as ... "We,re honored to be recognized by R&D ... of the past year," said Andreas Osten , medical ...
(Date:8/27/2014)...  CVS Caremark (NYSE: CVS ) announced ... with MedStar Health, a leading health care system with ... the Washington, DC , region, which ... for patients. Through this clinical affiliation, MedStar Health patients ... counseling, chronic disease monitoring and wellness programs at CVS/pharmacy ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
Cached News: